MORPHOMETRIC ESTIMATES OF INFILTRATIVE CELLULAR-CHANGES DURING THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN HAMSTERS

被引：0
|
作者：
CHANDLER, DB
HYDE, DM
GIRI, SN
机构：
[1] UNIV CALIF DAVIS,SCH VET MED,DEPT PHARMACOL & TOXICOL,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,SCH VET MED,DEPT ANAT,DAVIS,CA 95616
来源：
AMERICAN JOURNAL OF PATHOLOGY | 1983年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：170 / 177
页数：8
相关论文
共 50 条
  • [21] Treatment with α-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis
    Kimura, T
    Ishii, Y
    Morishima, Y
    Shibuya, A
    Shibuya, K
    Taniguchi, M
    Mochizuki, M
    Hegab, AE
    Sakamoto, T
    Nomura, A
    Sekizawa, K
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5782 - 5789
  • [22] Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis
    Zhu, J
    Cohen, DA
    Goud, SN
    Kaplan, AM
    CYTOKINES AND ADHESION MOLECULES IN LUNG INFLAMMATION, 1996, 796 : 194 - 202
  • [23] CHANGES IN THE LIPID-COMPOSITION OF BRONCHOALVEOLAR LAVAGE FLUID DURING THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN THE RAT
    SWENDSEN, CL
    SHANNON, TM
    KENNEDY, CA
    FREDERICK, D
    THRALL, RS
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1667 - 1667
  • [24] ADMINISTRATION OF ALPHA-PROTEINASE INHIBITOR AMELIORATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN HAMSTERS
    NAGAI, A
    AOSHIBA, K
    ISHIHARA, Y
    INANO, H
    SAKAMOTO, K
    YAMAGUCHI, E
    KAGAWA, J
    TAKIZAWA, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03): : 651 - 656
  • [25] Effects of TGF-β soluble receptor on bleomycin-induced pulmonary fibrosis in hamsters.
    Wang, O
    Wang, Y
    Hyde, DM
    Gotwals, P
    Koteliansky, V
    Giri, SN
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A71 - A71
  • [26] Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis
    Swendsen, CL
    Skita, V
    Thrall, RS
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (1-2): : 90 - 96
  • [27] Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters
    Mitsuhashi, H
    Asano, S
    Nonaka, T
    Hamamura, I
    Masuda, K
    Kiyoki, M
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (01) : 369 - 374
  • [28] Changes in Composition and Deposition of Glycosaminoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats
    Narayanan, V.
    Ouzzine, M.
    Ludwig, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [29] The impact of human hepatocyte growth factor in bleomycin-induced pulmonary fibrosis: a morphometric analysis
    Knudsen, L.
    Gazdhar, A.
    Temuri, A.
    Schmid, R.
    Ochs, M.
    Geiser, T.
    SWISS MEDICAL WEEKLY, 2009, 139 (13-14) : 8S - 8S
  • [30] Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis
    Venkatesan, N
    Pini, L
    Ludwig, MS
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (06) : L1342 - L1347
12345